YORK AGAINST CANCER

• ⚠

  Confirmation statement overdue

  Due 2026-04-30.

Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. About these numbers

• Turnover

  +29.6%

  £287,169 → £372,040

• Cash

  -33.6%

  £548,880 → £364,669

• Net assets

  +10%

  £4,060,891 → £4,466,498

• Employees

  0%

  10 → 10

• Operating profit

  +198.1%

  -£329,816 → £323,567

• Profit before tax

  +227.1%

  -£283,663 → £360,554

• Wages

  +20.7%

  £237,607 → £286,686

Each % is (latest − prior) ÷ |prior| for the line item as filed. The comparison is only shown when the latest and prior accounts cover broadly equal-length periods — short or long stubs (typical around incorporation or a year-end change) are suppressed rather than misrepresented. Lines a company doesn't report are omitted. About these numbers

Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.

Accounting basis

FRS 102

Reporting scope

Consolidated group

Auditor

Henton & Co LLP

Audit opinion

Unqualified (clean)

Going concern

Affirmed

“In auditing the financial statements, we have concluded that the directors' use of the going concern basis of accounting in the preparation of the financial statements is appropriate. Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the group's and parent charitable company's ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue.”

Group structure

1. YORK AGAINST CANCER · parent
   1. York Against Cancer Trading Company Limited 100% · England and Wales · raising of funds for the Charity through the sale of bought in goods through the Charity's two shops

Significant events

• “2024 was again a busy year for the Charity and the success of the Leveson Centre has certainly given York Against Cancer a further boost in visibility, meaning more people are now aware of what we do and can take advantage of the many services on offer.”
• “Mike Stower has stepped down from the Board of Trustees, although he continues to volunteer at events and in the Leveson Centre.”
• “Professor Jenny Southgate, who has led the Jack Birch Unit since 1999, will be retiring in 2025, and Will Brackenbury will be Jenny's successor.”
• “Dr Vicki Jennings joined in December 2024 for a five-year research fellowship supported by York Against Cancer, studying immunotherapies for epithelial cancers.”
• “A new Social Media Strategy was created to grow our supporter base; the charity ceased posting on platform X as its values do not align with York Against Cancer.”

Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers

Filings

3

last 12 months

Capital events

0

last 24 months

Officers appointed

0

last 12 months

Officers resigned

2

last 12 months

Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.